Vitamin D in winter: which level is really good and which is too much?
Between the minimum for your bones and the high dose from the internet lies a range that experts argue about. What studies show, why I aim for 40 to 60 ng/ml, when an injection may be the right fit and where too much begins.
A level just above the deficiency threshold does not mean you are well supplied. A level that keeps on rising does not mean you are better supplied. With vitamin D, it is not about more or less. It is about the range.
I bet you know this moment. It is February, just after four in the afternoon, and it is already getting dark outside. You slept for eight hours and you are still tired.
Coffee gets you through the morning, nothing more. The cold you caught in January is still in your bones. And somewhere you read that it might be your vitamin D.
Then the confusion begins. One website says 20 ng/ml is plenty. The next recommends 10,000 units a day. The third warns of toxicity.
May I ask you a question? Do you know your level? And do you know what it means?
This article sorts out the debate. Without fear and without hype. With what studies show, and with what I make of it in my practice.
Why the winter sun in Berlin is not enough for vitamin D is explained in the article Vitamin D deficiency: why winter sun is not enough. Symptoms and limits of an overdose are covered in depth in the article Vitamin D overdose: where meeting your needs ends and high-dose therapy begins. This article is about the question in between: which level is good?
Below 12 ng/ml (30 nmol/l), supply is clearly too low, and below 20 ng/ml (50 nmol/l) it counts as insufficient for the bones. Where good begins is disputed. In 2011, the Endocrine Society named at least 30 ng/ml, and since 2024 it has deliberately refrained from setting a target value. In my practice, when there are symptoms, I aim for 40 to 60 ng/ml, reached steadily and monitored. This is a clinical perspective, not a proven reference value. Toxicity usually only shows above 150 ng/ml, often with elevated calcium.
What to expect in this article
- Why your level drops in winter
- What ng/ml and nmol/l on your lab report mean
- Why medical societies disagree about the target value
- Why I aim for 40 to 60 ng/ml and where this position ends
- What vitamin D can do for infections and fatigue
- When an injection may make sense
- Where too much begins
- Three levers for your winter
A winter heavy as lead
I know this pattern very well. Someone comes to see me at the end of February. No drama, no diagnosis. Just a winter that refuses to end.
The sentence I often hear in moments like this:
We took blood and also looked at the common causes of exhaustion. The 25-OH vitamin D level was 14 ng/ml, which is around 35 nmol/l. A store that was almost empty.
Instead of relying on drops alone, we built up the store with an injection and scheduled the follow-up test right away. The injection was one building block, not the whole house.
The lesson: 14 ng/ml is not a whim of winter. It is a finding that deserves an answer.
Why does your level drop in winter, of all times?
From October onward, the sun in Berlin provides hardly any vitamin D, and your store lives off its reserves. In summer you notice none of this. You go outside, and your skin works for you. In winter it stops production, quietly and without warning.
Your skin is a solar panel. It needs UVB light to build vitamin D from a cholesterol precursor. When the sun is low, this light barely makes it through the atmosphere.
In 1988, a team led by Webb and Holick at Boston University exposed human skin samples and the vitamin D precursor to the winter sunlight of different cities.
In Boston, at 42 degrees north, no vitamin D was formed from November to February. In Edmonton, at 52 degrees north, this pause lasted from October to March. Further south, production continued even in the middle of winter.
What this means for you: at a little over 52 degrees north, Berlin lies at the same latitude as Edmonton. For half the year, the sun here delivers hardly any new supply.
Webb AR, Kline L, Holick MF. J Clin Endocrinol Metab. 1988;67(2):373-378. DOI: 10.1210/jcem-67-2-373In 2016, a team from Cork led by O'Neill calculated how much vitamin D-effective UVB light reaches Europe. The pattern is clear: the further north, the longer the vitamin D winter lasts. At 35 degrees north there is none, at 69 degrees north it lasts eight months.
The Robert Koch Institute in Berlin analyzed the blood levels of 6,995 adults from the nationwide DEGS1 health survey, collected between 2008 and 2011.
The mean was 45.6 nmol/l, a little over 18 ng/ml. In total, 61.6 percent were below 50 nmol/l, and 30.2 percent were even below 30 nmol/l. Lower levels were associated with measurement in winter, a more northern location, a higher BMI, little exercise and a lot of media use.
What this means for you: in Germany, a low winter level is more the rule than the exception. But common does not mean well supplied.
Rabenberg M, Scheidt-Nave C, Busch MA et al. BMC Public Health. 2015;15:641. DOI: 10.1186/s12889-015-2016-7A hormone that touches four systems
Strictly speaking, vitamin D is not a vitamin. It is the precursor of a hormone. The liver and kidneys convert it in two steps.
First, 25-OH vitamin D is formed. This is the storage form that circulates in the blood and that your lab measures. From it, the kidneys form active calcitriol, which regulates calcium balance. When the store drops, the parathyroid glands may release more parathyroid hormone to pull calcium out of the bone. That is the hormonal lens.
The lens of the immune system is at least as fascinating. In 2006, a team from Los Angeles led by Liu showed in the lab that human macrophages, the scavenger cells of the immune system, make their own active vitamin D when they are alerted by bacterial components. This leads to cathelicidin, an antimicrobial substance made by the body itself. Blood serum low in 25-OH vitamin D supported this response less well.
Imagine a field kitchen that only starts cooking when danger looms. It needs supplies in the storeroom. Your 25-OH level is that storeroom.
The nervous system also carries docking sites. In 2005, a team from Queensland led by Eyles found the vitamin D receptor and the activating enzyme in nerve and glial cells of the human brain, particularly densely in the hypothalamus. What this means for drive and mood in humans has not yet been conclusively clarified.
And then there is metabolism. Vitamin D is fat-soluble, and fat tissue can absorb it and hold on to it. In a large Canadian analysis led by Ekwaru, people with obesity had levels that were on average 19.8 nmol/l lower than those of people of normal weight. And the enzymes that convert vitamin D in the liver and kidneys all appear to need magnesium as a helper.
A low winter level is not a personal failure. It follows the latitude, the position of the sun and the season.
The question is not whether your level drops in winter. The question is from what level it drops.
And now you know why your February level often reveals more about your supply than your August level.
What do ng/ml and nmol/l on your lab report mean?
The same level can look entirely different on two lab reports, because labs measure in two different units. You are holding your lab report. It says 38. Or 15. Or 95. And you do not know whether that is good.
The reason is simple. Some labs report 25-OH vitamin D in ng/ml, others in nmol/l. The factor between them is 2.5. A value of 38 ng/ml therefore corresponds to 95 nmol/l. Same level, two numbers.
What is measured also matters. For your reserves, what counts is 25-OH vitamin D, also called calcidiol. As early as 2011, the Endocrine Society named this value as the first test when a deficiency is suspected. The active hormone 1,25-dihydroxyvitamin D, by contrast, has a half-life of only about 15 hours. It fluctuates too quickly to reflect your store.
The vitamin D scale: who calls which range what
Between 100 and 150 ng/ml lies a gray zone above the cautious upper limit. The reference ranges of your lab may differ.
The number on your lab report is not a verdict. It is a coordinate. Only together with the unit, the season and your symptoms does it become a meaningful statement.
And now you know why you should look at the unit first with every vitamin D value.
Why do medical societies disagree about the right level?
The major guidelines contradict each other less than it seems. They answer different questions. Perhaps you have already heard two doctors say opposite things. One finds 22 ng/ml perfectly fine. The other wants to get you to 40. Both have their reasons.
The bone perspective
20 ng/ml (50 nmol/l) covers the needs of at least 97.5 percent of the population, derived from bone health. Higher levels showed no consistent additional benefit.
The prevention perspective
From 30 ng/ml (75 nmol/l), supply counts as sufficient. This threshold was justified mainly with observational studies.
The humility perspective
No target value and no routine testing without a reason. Randomized trials provide no threshold above which a benefit reliably begins.
For its 2011 report, a committee of the Institute of Medicine in the US reviewed the entire body of evidence on calcium and vitamin D.
The committee considered the evidence solid for bone health, but not for cancer, heart disease, diabetes or autoimmune diseases. A level of 20 ng/ml covered the needs of at least 97.5 percent of the population. For some outcomes, U-shaped associations emerged, meaning risks at both low and high levels.
What this means for you: the 20 ng/ml is derived from the bone health of an entire population. It does not directly answer what an individual person with symptoms needs.
Ross AC, Manson JE, Abrams SA et al. J Clin Endocrinol Metab. 2011;96(1):53-58. DOI: 10.1210/jc.2010-2704In 2024, an international Endocrine Society panel led by Demay rewrote the vitamin D guideline, this time giving priority to randomized trials.
The panel suggests supplementation for children and adolescents, people aged 75 and over, pregnant women and people with high-risk prediabetes. For healthy adults under 75, it advises against doses above the reference intakes, and also against routine testing. In an accompanying paper, the society explains why it no longer supports its earlier classification: sufficient from 30 ng/ml, insufficient between 20 and 30 ng/ml. The certainty of the evidence for such a threshold, it says, is very low.
What this means for you: the new guideline does not say that your level does not matter. It says that studies have so far not provided a number above which a benefit reliably begins.
Demay MB, Pittas AG, Bikle DD et al. J Clin Endocrinol Metab. 2024;109(8):1907-1947. DOI: 10.1210/clinem/dgae290 · McCartney CR, McDonnell ME, Corrigan MD, Lash RW. J Clin Endocrinol Metab. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322“Epistemic humility means knowing where your own knowledge ends. For a guideline, that is not a weakness. It is honesty.”
Shukri Jarmoukli, ViveCura BerlinOther experts read the same data differently. A group led by Grant argues that many vitamin D trials studied people who were already well supplied, using rather low doses. From observational studies, the group derives thresholds above 30 ng/ml, and for some outcomes up to 40 or 50 ng/ml.
An international overview of guidelines led by Pludowski notes that natural sources are usually not enough for the population to maintain 30 to 50 ng/ml all year round. And a review from Graz led by Amrein points out that the fact that large trials found little may also be due to their mostly well-supplied participants. Vitamin D, the authors write, is not a miracle remedy and probably helps mainly when there is a deficiency.
Both can be true at the same time. Randomized trials are the gold standard for cause and effect. But they only answer the question they asked. And that question was usually: what does a fixed dose do for people who had no deficiency at all?
Guidelines do not disagree because one side understands nothing. They disagree because one particular kind of study is still rare: one that deliberately brings people with a true deficiency to different target levels and then compares them.
And now you know why two smart people can reach different conclusions from the same number.
Why do I aim for 40 to 60 ng/ml?
For me, 40 to 60 ng/ml is a range with a buffer below and a margin above. Not a record you have to break.
Perhaps you are thinking: if even the medical societies do not name a target value, why do you? Good question. I want to answer it honestly, with reasons and with limits.
A look at life in the sun
People who live traditionally under the East African sun all year round had an average of around 46 ng/ml. This shows where a body without winter can end up.
The winter buffer
25-OH vitamin D has a half-life of about 15 days, and from October to March hardly any new supply comes in. If you start higher in autumn, you have more leeway until March.
The safety margin
Toxicity typically shows above 150 ng/ml, and 100 ng/ml is considered a cautious upper limit. 60 ng/ml is far below that.
Every body does the math differently
The same dose raises the level very differently depending on weight and starting level. A range with testing fits this better than one fixed number for everyone.
In 2012, a team from Groningen led by Luxwolda measured vitamin D levels in Maasai and Hadzabe people in Tanzania. They live traditionally, spend most of the day outdoors and avoid direct sun where they can.
The mean was 115 nmol/l, around 46 ng/ml. The range ran from 58 to 171 nmol/l, which is around 23 to 68 ng/ml. Age, sex and BMI played no discernible role.
What this means for you: a body under year-round sun ends up at around 46 ng/ml on average. The authors themselves write that whether this is optimal under Western conditions remains open. A clue about physiology, not proof of a benefit.
Luxwolda MF, Kuipers RS, Kema IP, Dijck-Brouwer DA, Muskiet FA. Br J Nutr. 2012;108(9):1557-1561. DOI: 10.1017/S0007114511007161In 2015, a Mayo Clinic team led by Dudenkov analyzed ten years of vitamin D measurements from an entire county in Minnesota.
Values above 50 ng/ml became much more common during this period, rising from 9 to 233 cases per 100,000 person-years. Overall, no association with elevated blood calcium emerged. In four cases, a high level and elevated calcium occurred at the same time, and there was one true case of toxicity, at 364 ng/ml.
What this means for you: a level above 50 ng/ml is not toxicity in itself. The danger zone lies much higher.
Dudenkov DV, Yawn BP, Oberhelman SS et al. Mayo Clin Proc. 2015;90(5):577-586. DOI: 10.1016/j.mayocp.2015.02.012Where this position ends
Now comes the part I do not want to spare you. There are data that put question marks over higher levels. Anyone who advocates a target range needs to know them.
In 2012, a team from Copenhagen led by Durup analyzed the vitamin D levels of 247,574 people from general practices and tracked mortality.
Mortality was lowest at 50 to 60 nmol/l, which is 20 to 24 ng/ml. At 10 nmol/l, the risk was more than twice as high, and at 140 nmol/l it was 42 percent higher than at 50 nmol/l. Cause and effect explicitly could not be derived from this.
What this means for you: there are question marks at the upper end too. One possible explanation is that sick people are tested more often and take higher doses. That is not proven, and that is exactly why I take these data seriously.
Durup D, Jørgensen HL, Christensen J et al. J Clin Endocrinol Metab. 2012;97(8):2644-2652. DOI: 10.1210/jc.2012-1176An Australian team led by Neale gave 21,315 people aged 60 and over either 60,000 IU of vitamin D or a placebo once a month for five years.
The vitamin D group averaged 115 nmol/l, the placebo group 77 nmol/l. Mortality did not decrease. In an exploratory analysis, cancer mortality was even slightly higher in the vitamin D group. The authors therefore advise caution with this regimen in people who are already well supplied.
What this means for you: if you are already well supplied, a monthly high dose apparently adds nothing. A target range for people with a deficiency is something different from a high dose for everyone.
Neale RE, Baxter C, Romero BD et al. Lancet Diabetes Endocrinol. 2022;10(2):120-128. DOI: 10.1016/S2213-8587(21)00345-4The Institute of Medicine also described U-shaped curves for some outcomes. And the Endocrine Society considers the evidence for any threshold to be very uncertain. I take both seriously, and it shapes how I use the target range.
Well established: Below 12 ng/ml, supply is too low, and below 20 ng/ml it is insufficient for the bones. Large high doses at infrequent intervals brought no advantage in studies and sometimes disadvantages.
Plausible, but not proven: 40 to 60 ng/ml roughly corresponds to what people reach under year-round sun. The range leaves a buffer for winter and stays far below the toxicity threshold.
Open: No large randomized trial has yet shown whether 40 to 60 ng/ml benefits a person more than 30 ng/ml. Some observational data put question marks over higher levels.
What I make of it: I aim for 40 to 60 ng/ml in people with symptoms and a low starting level, reached steadily and monitored. For healthy people without symptoms, this is not a must. I do not aim beyond 60 ng/ml.
A target range is not a competition. Someone at 58 ng/ml is not healthier than someone at 42. Both are within the range. Here, more is not more.
And now you know why I talk about a range and not a number.
What can a good level do for infections and fatigue?
Vitamin D is not a turbo boost for healthy people. It can fill a gap where there is a gap. Winter has two faces that many people know: the third cold since October and a leaden fatigue. No wonder vitamin D is touted as the rescue for both.
In 2017, a team led by Martineau at Queen Mary University of London pooled the individual data of 10,933 people from 25 randomized trials.
Overall, vitamin D slightly lowered the risk of acute respiratory infections. The effect appeared with daily or weekly dosing, not with large single doses. It was most pronounced in people who started below 25 nmol/l, that is, below 10 ng/ml.
What this means for you: those who lacked the most benefited the most. And they did so with steady dosing.
Martineau AR, Jolliffe DA, Hooper RL et al. BMJ. 2017;356:i6583. DOI: 10.1136/bmj.i6583The same research team has updated its analysis several times. In 2021, across 37 trials, a small protective effect still appeared, most likely with daily doses of 400 to 1,000 IU.
In the 2025 update, with 61,589 people from 40 trials, the effect narrowly missed statistical significance, with an odds ratio of 0.94. The researchers no longer found any difference by starting level, dose or dosing regimen.
What this means for you: vitamin D is not a shield against every infection. If there is an effect in the general population, it is small.
Jolliffe DA, Camargo CA, Sluyter JD et al. Lancet Diabetes Endocrinol. 2021;9(5):276-292. DOI: 10.1016/S2213-8587(21)00051-6 · Jolliffe DA, Camargo CA, Sluyter JD et al. Lancet Diabetes Endocrinol. 2025;13(4):307-320. DOI: 10.1016/S2213-8587(24)00348-6The large VITAL trial fits this picture too. In it, 25,871 adults took 2,000 IU of vitamin D or a placebo daily for a little over five years. Cancer and major cardiovascular events did not become less frequent. A deficiency was not a requirement for taking part. And excess calcium did not occur more often at this daily dose.
And fatigue? Here there is a small but interesting study.
In 2016, a team from Zurich led by Nowak studied 120 young adults who complained of exhaustion and had levels below 20 ng/ml.
A single oral dose of vitamin D lowered fatigue scores after four weeks significantly more than a placebo. In the vitamin D group, 72 percent reported an improvement, compared with 50 percent on placebo. The improvement was linked, if only weakly, to the rise in the level.
What this means for you: with a true deficiency, vitamin D may ease exhaustion. But half of the placebo group also felt better. Fatigue almost always has more than one cause.
Nowak A, Boesch L, Andres E et al. Medicine (Baltimore). 2016;95(52):e5353. DOI: 10.1097/MD.0000000000005353Energy in February is not a luxury. It decides whether you live your winter or just get through it.
That is exactly why it pays to look beyond vitamin D. Fatigue in winter can have many causes. They include iron deficiency, a thyroid that is not running smoothly despite medication, poor sleep and simply a lack of light. What vitamin D can do in the immune system and where the data end is explored in depth in the article Vitamin D and the immune system: what is proven, what remains open.
Vitamin D is not a turbo boost. It is a gap filler, and that is exactly where its strength lies. Where there is a gap, it can make a big difference. Where there is none, more of it does little.
And now you know why, with fatigue, I test first and decide afterwards.
When can a vitamin D injection make sense?
The injection is not an upgrade for everyone. It is a tool for a true deficiency. Perhaps this sounds familiar: the drops sit in the cupboard, and you forget them every other day. Or you take them diligently, and your level still barely moves.
In my practice, I can also give vitamin D as an injection into the muscle. This is an option, not the standard. Most people do well with drops or tablets.
An injection into the muscle creates a small depot. From there, vitamin D enters the blood over weeks, without a detour through the gut. Imagine a battery that slowly releases power. Drops are more like daily recharging.
In 2013, a team from Sapienza University in Rome led by Cipriani gave people with low levels a single high dose of vitamin D, either by mouth or into the muscle.
After oral intake, the level initially rose more sharply and was broken down again quickly. After the injection, it rose slowly and only reached its peak after about four months.
What this means for you: the injection is not a quick kick but a slow build-up. Knowing this, you can check your level at the right time.
Cipriani C, Romagnoli E, Pepe J et al. J Clin Endocrinol Metab. 2013;98(7):2709-2715. DOI: 10.1210/jc.2013-1586In 2017, a team from Charité Berlin led by Wylon compared a single injection of 100,000 IU with daily oral intake over twelve weeks.
Four weeks after the injection, the mean level was 70.9 nmol/l, compared with 32.7 nmol/l in the comparison group without vitamin D. The rise after 28 days was comparable for both routes.
What this means for you: both routes can raise your level. Which one fits better is a question of your situation, not of principle.
Wylon K, Drozdenko G, Krannich A et al. PLoS One. 2017;12(1):e0169620. DOI: 10.1371/journal.pone.0169620Other studies paint a mixed picture. In a Turkish study of older people, the level twelve weeks after a high intramuscular dose was 52 ng/ml, and after the same dose by mouth it was 43 ng/ml. Overall, 9.6 percent of participants had too much calcium in their urine afterwards. A study from Tehran, by contrast, found the oral route ahead after three months and no difference after six months. The choice also depends on preference, adherence and availability, the authors write.
Drops and tablets
- Daily or weekly dosing, the best studied approach
- The dose can be finely adjusted
- Needs a routine and a gut that absorbs fat well
- The right route for most people
Injection into the muscle
- A depot from which the level rose slowly and steadily in studies
- Independent of your gut and your memory
- A high single dose: testing before, follow-up afterwards
- Not meant as an annual ritual for people who are well supplied
When I consider an injection
- A measured, clear deficiency, usually well below 20 ng/ml, together with symptoms
- Signs of impaired fat absorption, for example with chronic bowel diseases or after surgery on the gastrointestinal tract
- Drops that barely move the level despite regular intake
- A daily life in which taking something every day simply does not work
And when rather not? With a good starting level, with elevated blood calcium, with a history of kidney stones, and with conditions such as sarcoidosis without prior medical assessment.
In 2007, a team from Southampton led by Smith reported on a trial in which people aged 75 and over received an injection of 300,000 IU of vitamin D2 or a placebo every autumn for three years.
Fractures overall did not become less frequent. Hip fractures even occurred more often in the vitamin D group, and the injection had no effect on falls.
What this means for you: an injection is not an annual ritual for everyone. It belongs specifically to a measured deficiency, with a plan for afterwards.
Smith H, Anderson F, Raphael H et al. Rheumatology (Oxford). 2007;46(12):1852-1857. DOI: 10.1093/rheumatology/kem240The injection is not the stronger version of the drops. It is a different tool for a different situation. Whether it fits is decided by your lab results, not by the wish for the fastest route.
And now you know why the question is not: drops or injection? It is: what does your store need, and by which route does it get there?
Where does too much begin?
Too much does not only begin with toxicity. It begins where the dose keeps going up without testing. On the other side of the debate are the high-dose tips. Their advice: 10,000 units a day, because more must surely be better. That sounds bold. But it can tip over.
Vitamin D is fat-soluble. What you take in excess, you do not simply excrete. The body stores it in fat tissue, and the half-life of vitamin D itself is around two months. An excess therefore builds up slowly and breaks down slowly.
Things become critical through calcium. Very high levels can cause too much calcium to pass from the gut and bones into the blood. In medicine, this is called hypercalcemia. It can strain the kidneys, heart and nerves.
In 2018, a team from Warsaw and Kingston led by Marcinowska-Suchowierska summarized what is known about vitamin D toxicity.
The typical laboratory sign of an overdose is a level above 150 ng/ml, usually with elevated calcium. Common symptoms are confusion, lack of drive, repeated vomiting, abdominal pain, frequent urination, intense thirst and dehydration. In granulomatous diseases such as sarcoidosis and in some lymphomas, the body itself can produce too much active vitamin D.
What this means for you: toxicity is rare and usually requires very high doses over a longer period. With certain conditions, however, the limit can be much lower.
Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Front Endocrinol (Lausanne). 2018;9:550. DOI: 10.3389/fendo.2018.00550Where is the limit for intake? In 2023, the European Food Safety Authority (EFSA) set the tolerable upper intake level for adults at 100 µg per day, which is 4,000 IU. It was derived from studies in which increased calcium in the urine appeared from 250 µg daily. For children aged 1 to 10, it is 50 µg. This upper level is not a recommendation, but a guardrail for long-term total daily intake.
And then there is the question of how you get there. Here the data are surprisingly clear.
A team from Geelong in Australia led by Sanders gave 2,256 women aged 70 and over a single oral dose of 500,000 IU of vitamin D every autumn or winter.
The vitamin D group had more falls and more fractures than the placebo group. The risk of falling was most clearly increased in the first three months after the dose. During this time, the level rose to about 120 nmol/l after one month.
What this means for you: it is not only the height of the level that counts, but also the way you get there. A sudden jump is something different from a steady reserve.
Sanders KM, Stuart AL, Williamson EJ et al. JAMA. 2010;303(18):1815-1822. DOI: 10.1001/jama.2010.594In a Zurich study of 200 people aged 70 and over, more participants fell on 60,000 IU monthly than on 24,000 IU, 66.9 versus 47.9 percent. Leg function did not improve with the higher doses. A meta-analysis of 15 trials found no protection against falls and fractures for infrequent or single high doses, and for falls rather a trend toward more.
Physiology offers an explanation. The parent compound vitamin D circulates in the blood only briefly. Tissues that activate it locally probably benefit from a steady daily supply, as Hollis and Wagner argue in a review. This is mechanistically plausible, but not conclusively proven. In line with this, the Endocrine Society suggests daily doses instead of infrequent high doses for people aged 50 and over.
Before you go higher, you should know
- How high your starting level is, measured as 25-OH vitamin D
- Whether your blood calcium and kidney values are unremarkable
- Whether you have had kidney stones or have a condition such as sarcoidosis
- Which supplements you already take, including those hidden in combination products
- When the follow-up test will happen, at the earliest after eight to twelve weeks
You will find symptoms, limits and high-dose protocols in detail in the article Vitamin D overdose: where meeting your needs ends and high-dose therapy begins.
The danger rarely lies in the supplement. It lies in flying blind. If you test, you see where you stand. If you only increase the dose, you often notice only when your body speaks up.
And now you know why, with vitamin D, I would rather test twice than give too much once.
Do you need magnesium and K2 as well?
Vitamin D does not work alone. Magnesium is the most important teammate, K2 a sensible option. Perhaps you have been taking vitamin D for months, and your level is not budging. Then it is worth looking at the whole team, not just the striker.
A review by Uwitonze and Razzaque describes it like this: all the enzymes that convert vitamin D in the liver and kidneys appear to need magnesium as a helper. If magnesium is lacking, the conversion can stall.
In 2018, a team from Vanderbilt University led by Dai gave 180 adults aged 40 to 85 either magnesium or a placebo, with the dose adjusted to their diet.
If the vitamin D level at the start was around 30 ng/ml, it rose with magnesium. If it was higher, between about 30 and 50 ng/ml, it fell slightly.
What this means for you: magnesium appears to help the level settle, like a thermostat. A good magnesium status can help vitamin D arrive where it is supposed to go.
Dai Q, Zhu X, Manson JE et al. Am J Clin Nutr. 2018;108(6):1249-1258. DOI: 10.1093/ajcn/nqy274And K2? Vitamin D stimulates the production of certain proteins, such as osteocalcin in bone. These proteins only become functional with vitamin K. They are involved in building calcium into bone and keeping it out of the vessel walls. A review from Amsterdam and Graz led by van Ballegooijen considers taking the two together possibly more favorable for bones and blood vessels than either one alone. The number of intervention studies, however, is small.
You will find more on practical intake in the articles Taking vitamin D the right way: why you go in circles without magnesium and K2 and Vitamin K2 and D3: where calcium travels in your body. Which form of magnesium suits which purpose is compared in the article Which magnesium is the best?
Vitamin D is the letter. Magnesium is the mail carrier. Without the carrier, the message can get stuck in the sorting center.
And now you know why, when a level will not move, I also ask about magnesium.
Three levers for your winter
February will come either way. The question is what kind of store you meet it with.
This is not about a number on a lab slip. It is about winter not taking a piece of your quality of life every year.
Measure the right value at the right time
Have your 25-OH vitamin D measured, not the active hormone. Late winter shows the low point, late summer the starting point. Note down the unit and convert with the factor 2.5 if needed.
Steady rather than rare and large
Daily or weekly doses did better in studies than large single doses. Which dose suits you depends on your starting level, weight and goal. In the Canadian analysis, going from zero to 1,000 IU daily raised the level by about 12 nmol/l on average, just under 5 ng/ml. At high doses, the increase became much smaller. The DGE's 800 IU is intended as a reference intake for the population. Bringing an almost empty store up to 40 ng/ml is a different task, and it belongs under medical supervision.
With a true deficiency: replenish with a plan
If your level is well below 20 ng/ml and you have symptoms, a medically supervised build-up is worthwhile, depending on the situation via drops or as an injection. Before that, calcium and kidney values belong on the table, and afterwards a fixed follow-up appointment after eight to twelve weeks. And if the level does not move, it is worth looking at magnesium and at absorption in the gut.
Well established: In Germany, many people are below 20 ng/ml in winter, and at Berlin's latitude the skin makes hardly any vitamin D from October to March. Large single doses at infrequent intervals brought no advantage in studies and sometimes more falls and fractures. Toxicity typically only shows above 150 ng/ml, and EFSA sets the daily upper limit for adults at 4,000 IU.
Plausible, with mixed data: With a true deficiency and steady dosing, susceptibility to infections and fatigue may be favorably influenced. For well-supplied people, large studies show hardly any benefit.
My clinical perspective: The target range of 40 to 60 ng/ml when there are symptoms, and the injection as an option for a true deficiency, are based on physiology, safety margins and experience. Studies proving this range to be superior do not exist so far.
Vitamin D is neither a miracle remedy nor a danger. It is a store that runs empty in winter.
Between the minimum for your bones and the high dose from the internet lies a range in which your body can work well. You will not find it on the shelf, but in the lab.
Frequently asked questions
Which vitamin D level is optimal?
There is no optimal value that has been proven for everyone. The German Nutrition Society (DGE) and the Institute of Medicine consider 20 ng/ml (50 nmol/l) sufficient. In 2011, the Endocrine Society named at least 30 ng/ml, and since 2024 it has deliberately not set a target value. In my practice, when there are symptoms and a low starting level, I aim for 40 to 60 ng/ml. This is a functional, clinical perspective and not a reference value proven by studies. The range should be reached steadily and with monitoring, not with megadoses.
At what level is there a vitamin D deficiency?
Below 12 ng/ml (30 nmol/l), supply is clearly too low, and this range should be avoided whenever possible. Between 12 and 20 ng/ml (30 to 50 nmol/l), supply counts as insufficient for the bones according to the DGE and the Institute of Medicine. In the German DEGS1 study, 61.6 percent of adults were below 50 nmol/l and 30.2 percent below 30 nmol/l. Low levels are more common in winter and spring.
How do I convert ng/ml to nmol/l?
You multiply the value in ng/ml by 2.5 and get approximately nmol/l. So 20 ng/ml corresponds to about 50 nmol/l, 40 ng/ml to about 100 nmol/l and 60 ng/ml to about 150 nmol/l. In the other direction, you divide by 2.5. For supplements, a second conversion applies: 1 µg of vitamin D equals 40 international units, so 20 µg is 800 IU. Always check your lab report first to see which unit your lab uses.
Why 40 to 60 ng/ml if 20 ng/ml is officially enough?
Because the 20 ng/ml was derived from the bone health of an entire population, not from the symptoms of individual people. Traditionally living groups in East Africa with year-round sun had an average of 115 nmol/l, around 46 ng/ml. A level in this range leaves a buffer for the dark months and stays far below the toxicity threshold. However, randomized trials have not shown an additional benefit compared with 30 ng/ml. That is why it is a reasoned target zone, not an obligation for everyone.
At what level is vitamin D too much?
Vitamin D toxicity typically shows at levels above 150 ng/ml (375 nmol/l), usually together with elevated blood calcium. As a cautious upper limit with a wide safety margin, 100 ng/ml (250 nmol/l) is under discussion. EFSA sets the tolerable upper intake level for adults at 100 µg per day, which is 4,000 IU. For levels above 60 ng/ml, there is no proven additional benefit. With conditions such as sarcoidosis, even a usual dose can be too much.
When does a vitamin D injection make sense?
It can make sense when there is a true, measured deficiency and the store needs to be built up reliably. Typical reasons are symptoms with a very low level, impaired fat absorption in the gut or difficulties with regular intake. In studies, the level rose more slowly and steadily after an intramuscular injection than after a large oral dose. An injection is still a high single dose and belongs in medical hands, with testing beforehand and a follow-up afterwards. It is not intended for people who are well supplied.
Are high single doses just as good as daily intake?
The evidence tends to favor steady dosing. A once-yearly dose of 500,000 IU led to more falls and fractures in older women, especially in the first three months afterwards. A meta-analysis of 15 trials found no protection against falls and fractures with infrequent high doses. For respiratory infections, a benefit tended to appear with daily or weekly dosing. The Endocrine Society therefore suggests daily doses instead of infrequent high doses from age 50.
When should I have my vitamin D level measured?
A test makes sense when symptoms, risk factors or planned supplementation call for a decision. What is measured is 25-OH vitamin D, not the active hormone 1,25-dihydroxyvitamin D. The lowest point is usually at the end of winter. After you start taking vitamin D, a follow-up test is worthwhile after eight to twelve weeks at the earliest, because 25-OH vitamin D has a half-life of about 15 days. For healthy people without a specific reason, the Endocrine Society advises against routine testing.
How much vitamin D do the DGE and RKI recommend?
The German Nutrition Society (DGE) estimates the requirement in the absence of the body's own production in the skin at 20 µg per day, which is 800 IU. This is meant to achieve a level of at least 50 nmol/l, that is 20 ng/ml. The Robert Koch Institute (RKI) uses the same threshold in its population studies. According to the DGE, this requirement cannot be met through the usual diet alone, so sun or supplementation has to close the gap. It is a value for the population, not an individual treatment plan.
Do I need magnesium and K2 with vitamin D?
Magnesium is involved in the enzymes that convert vitamin D in the liver and kidneys. In a randomized trial, the level rose with magnesium when it was around 30 ng/ml. When it was higher, it fell slightly, so magnesium seemed to help it settle. Vitamin K2 makes proteins functional that are involved in building calcium into bone. However, the evidence for taking them together comes mainly from mechanisms and smaller studies. A balanced magnesium status makes sense, and K2 is an option, not a must.
Can vitamin D help with winter fatigue?
With a true deficiency, possibly yes. In a Zurich study of 120 exhausted people below 20 ng/ml, a single dose of vitamin D improved fatigue more than a placebo. In the vitamin D group, 72 percent reported an improvement, compared with 50 percent on placebo. If you are well supplied, however, you can expect little from more vitamin D. Fatigue has many possible causes, such as iron deficiency, the thyroid, sleep or lack of light, and should therefore be assessed holistically.
How does this article differ from the other vitamin D articles?
The article on vitamin D deficiency in winter explains why the sun in Berlin is not enough from October to March. The article on overdose goes deeper into symptoms, limits and high-dose protocols. This article sits in between: it addresses which level can be considered good, why medical societies disagree about it, when an injection may be the right fit and where too much begins. The texts complement each other.
Further reading in Guide Supplements
More on vitamin D and supplements
- Vitamin D deficiency: why winter sun is not enough
- Vitamin D overdose: where meeting your needs ends and high-dose therapy begins
- Taking vitamin D the right way: why you go in circles without magnesium and K2
- Vitamin K2 and D3: where calcium travels in your body
- Vitamin D and the immune system: what is proven, what remains open
- How much sun does the body need? Between fear of skin cancer and deficiency
- Do I need supplements at all? Blood tests instead of gut feeling
- Micronutrient analysis: what whole blood shows and the serum value misses
- Which magnesium is the best? The forms in an honest comparison
- All articles in Guide Supplements
Related topics
Supplements
Nutrients, lab tests and well-founded supplementation
This articleLight and mood
When the dark season weighs on your mind
Iron
Ferritin, fatigue and energy
Thyroid
Tired despite good levels
Sources
All studies were researched via PubMed and checked against the PubMed metadata (title, authors, year, journal, DOI). Key papers were additionally cross-checked via Consensus, and for several of them the DOI resolution was tested directly. The study type is given in square brackets.
- Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67(2):373-378. DOI: 10.1210/jcem-67-2-373 [In vitro, skin samples and 7-dehydrocholesterol under sunlight]
- O'Neill CM, Kazantzidis A, Ryan MJ et al. Seasonal Changes in Vitamin D-Effective UVB Availability in Europe and Associations with Population Serum 25-Hydroxyvitamin D. Nutrients. 2016;8(9):533. DOI: 10.3390/nu8090533 [Real-world, UVB modeling from 35 to 69 degrees north with population data]
- Rabenberg M, Scheidt-Nave C, Busch MA, Rieckmann N, Hintzpeter B, Mensink GB. Vitamin D status among adults in Germany: results from the German Health Interview and Examination Survey for Adults (DEGS1). BMC Public Health. 2015;15:641. DOI: 10.1186/s12889-015-2016-7 [Real-world, cross-sectional, DEGS1, n=6,995]
- Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770-1773. DOI: 10.1126/science.1123933 [In vitro, human macrophages and serum samples]
- Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21-30. DOI: 10.1016/j.jchemneu.2004.08.006 [In vitro, human brain tissue, immunohistochemistry]
- Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014;9(11):e111265. DOI: 10.1371/journal.pone.0111265 [Real-world, prevention program, n=17,614]
- Uwitonze AM, Razzaque MS. Role of Magnesium in Vitamin D Activation and Function. J Am Osteopath Assoc. 2018;118(3):181-189. DOI: 10.7556/jaoa.2018.037 [Mechanistic review]
- Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. DOI: 10.1210/jc.2011-0385 [Overview: Endocrine Society guideline 2011, consensus based on systematic reviews]
- Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(2):582S-586S. DOI: 10.1093/ajcn/88.2.582S [Review, pharmacokinetics and toxicity]
- Amrein K, Scherkl M, Hoffmann M et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74(11):1498-1513. DOI: 10.1038/s41430-020-0558-y [Narrative review]
- German Nutrition Society. New reference values for vitamin D. Ann Nutr Metab. 2012;60(4):241-246. DOI: 10.1159/000337547 [Official document, D-A-CH reference values of the German Nutrition Society]
- Ross AC, Manson JE, Abrams SA et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58. DOI: 10.1210/jc.2010-2704 [Official document, summary of the IOM report]
- McCartney CR, McDonnell ME, Corrigan MD, Lash RW. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. J Clin Endocrinol Metab. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322 [Overview, rationale for the 2024 guideline]
- Pludowski P, Holick MF, Grant WB et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018;175:125-135. DOI: 10.1016/j.jsbmb.2017.01.021 [Review, international guidelines compared]
- Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D Toxicity: A Clinical Perspective. Front Endocrinol (Lausanne). 2018;9:550. DOI: 10.3389/fendo.2018.00550 [Clinical review]
- Demay MB, Pittas AG, Bikle DD et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. DOI: 10.1210/clinem/dgae290 [Systematic review with GRADE guideline, 14 clinical questions]
- Grant WB, Al Anouti F, Boucher BJ et al. A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health. Nutrients. 2022;14(3):639. DOI: 10.3390/nu14030639 [Narrative review, mainly observational data]
- Luxwolda MF, Kuipers RS, Kema IP, Dijck-Brouwer DA, Muskiet FA. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr. 2012;108(9):1557-1561. DOI: 10.1017/S0007114511007161 [Real-world, cross-sectional, n=60]
- Dudenkov DV, Yawn BP, Oberhelman SS et al. Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study. Mayo Clin Proc. 2015;90(5):577-586. DOI: 10.1016/j.mayocp.2015.02.012 [Real-world, population study, 20,308 measurements]
- Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab. 2012;97(8):2644-2652. DOI: 10.1210/jc.2012-1176 [Real-world, retrospective cohort, n=247,574]
- Neale RE, Baxter C, Romero BD et al. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. 2022;10(2):120-128. DOI: 10.1016/S2213-8587(21)00345-4 [RCT, D-Health, n=21,315]
- Martineau AR, Jolliffe DA, Hooper RL et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. DOI: 10.1136/bmj.i6583 [Meta-analysis, individual participant data from 25 RCTs, n=10,933]
- Jolliffe DA, Camargo CA, Sluyter JD et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9(5):276-292. DOI: 10.1016/S2213-8587(21)00051-6 [Meta-analysis, 46 RCTs, primary outcome data from 48,488 participants]
- Jolliffe DA, Camargo CA, Sluyter JD et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes Endocrinol. 2025;13(4):307-320. DOI: 10.1016/S2213-8587(24)00348-6 [Meta-analysis, 40 trials, n=61,589]
- Manson JE, Cook NR, Lee IM et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2019;380(1):33-44. DOI: 10.1056/NEJMoa1809944 [RCT, VITAL, n=25,871]
- Nowak A, Boesch L, Andres E et al. Effect of vitamin D3 on self-perceived fatigue: A double-blind randomized placebo-controlled trial. Medicine (Baltimore). 2016;95(52):e5353. DOI: 10.1097/MD.0000000000005353 [RCT, n=120]
- Cipriani C, Romagnoli E, Pepe J et al. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. J Clin Endocrinol Metab. 2013;98(7):2709-2715. DOI: 10.1210/jc.2013-1586 [RCT, pharmacokinetics, n=24]
- Wylon K, Drozdenko G, Krannich A, Heine G, Dölle S, Worm M. Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol. PLoS One. 2017;12(1):e0169620. DOI: 10.1371/journal.pone.0169620 [Pharmacokinetic study, two cohorts with comparison groups, Charité Berlin]
- Tellioglu A, Basaran S, Guzel R, Seydaoglu G. Efficacy and safety of high dose intramuscular or oral cholecalciferol in vitamin D deficient/insufficient elderly. Maturitas. 2012;72(4):332-338. DOI: 10.1016/j.maturitas.2012.04.011 [RCT, n=66]
- Zabihiyeganeh M, Jahed A, Nojomi M. Treatment of hypovitaminosis D with pharmacologic doses of cholecalciferol, oral vs intramuscular; an open labeled RCT. Clin Endocrinol (Oxf). 2013;78(2):210-216. DOI: 10.1111/j.1365-2265.2012.04518.x [RCT, open-label, n=92]
- Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women: a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007;46(12):1852-1857. DOI: 10.1093/rheumatology/kem240 [RCT, n=9,440]
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T et al. Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate. EFSA J. 2023;21(8):e08145. DOI: 10.2903/j.efsa.2023.8145 [Official document, EFSA, based on systematic reviews]
- Sanders KM, Stuart AL, Williamson EJ et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815-1822. DOI: 10.1001/jama.2010.594 [RCT, n=2,256]
- Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ et al. Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial. JAMA Intern Med. 2016;176(2):175-183. DOI: 10.1001/jamainternmed.2015.7148 [RCT, n=200]
- Myung SK, Cho H. Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis. Osteoporos Int. 2023;34(8):1355-1367. DOI: 10.1007/s00198-023-06761-3 [Meta-analysis, 15 RCTs]
- Hollis BW, Wagner CL. Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab. 2013;98(12):4619-4628. DOI: 10.1210/jc.2013-2653 [Mechanistic review]
- Dai Q, Zhu X, Manson JE et al. Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial. Am J Clin Nutr. 2018;108(6):1249-1258. DOI: 10.1093/ajcn/nqy274 [RCT, n=180]
- van Ballegooijen AJ, Pilz S, Tomaschitz A, Grübler MR, Verheyen N. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review. Int J Endocrinol. 2017;2017:7454376. DOI: 10.1155/2017/7454376 [Narrative review]